Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Autor: | Yang, C.H., Gonzalez-Angulo, A.M., Reuben, J.M., Booser, D.J., Pusztai, L., Krishnamurthy, S., Esseltine, D., Stec, J., Broglio, K.R., Islam, R., Hortobagyi, G.N., Cristofanilli, M. * |
---|---|
Zdroj: | In Annals of Oncology May 2006 17(5):813-817 |
Databáze: | ScienceDirect |
Externí odkaz: |